[HTML][HTML] Moxidectin and the avermectins: consanguinity but not identity

R Prichard, C Ménez, A Lespine - … Journal for Parasitology: Drugs and Drug …, 2012 - Elsevier
The avermectins and milbemycins contain a common macrocyclic lactone (ML) ring, but are
fermentation products of different organisms. The principal structural difference is that …

[HTML][HTML] Disease-drug and drug-drug interaction in COVID-19: Risk and assessment

D Kumar, N Trivedi - Biomedicine & Pharmacotherapy, 2021 - Elsevier
COVID-19 is announced as a global pandemic in 2020. Its mortality and morbidity rate are
rapidly increasing, with limited medications. The emergent outbreak of COVID-19 prompted …

[HTML][HTML] Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor …

AC Kotze, PW Hunt, P Skuce… - International Journal for …, 2014 - Elsevier
Anthelmintic resistance has a great impact on livestock production systems worldwide, is an
emerging concern in companion animal medicine, and represents a threat to our ongoing …

[HTML][HTML] P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: prospects for reversing transport-dependent anthelmintic …

A Lespine, C Ménez, C Bourguinat… - International Journal for …, 2012 - Elsevier
Parasitic helminths cause significant disease in animals and humans. In the absence of
alternative treatments, anthelmintics remain the principal agents for their control. Resistance …

Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics

C Ambrus, É Bakos, B Sarkadi, C Özvegy-Laczka… - Scientific reports, 2021 - nature.com
Transporters in the human liver play a major role in the clearance of endo-and xenobiotics.
Apical (canalicular) transporters extrude compounds to the bile, while basolateral …

Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety

C Chaccour, F Hammann, NR Rabinovich - Malaria Journal, 2017 - Springer
Ivermectin is an endectocide that has been used broadly in single dose community
campaigns for the control of onchocerciasis and lymphatic filariasis for more than 30 years …

Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects

SP Rendic - Archives of Toxicology, 2021 - Springer
The review presents metabolic properties of Ivermectin (IVM) as substrate and inhibitor of
human P450 (P450, CYP) enzymes and drug transporters. IVM is metabolized, both in vivo …

P-glycoproteins in anthelmintic safety, efficacy, and resistance

A Lespine, C Blancfuney, R Prichard, M Alberich - Trends in Parasitology, 2024 - cell.com
P-glycoprotein (PGP) is a pivotal transmembrane transporter governing the cellular flux of
diverse substances shielding mammals from toxics. It can thwart the effectiveness of …

Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics

M Jani, C Ambrus, R Magnan, KT Jakab, E Beéry… - Archives of …, 2014 - Springer
The discovery and characterization of breast cancer resistance protein (BCRP) as an efflux
transporter conferring multidrug resistance has set off a remarkable trajectory in the …

Central effects of ivermectin in alleviation of Covid-19-induced dysautonomia

HM Al-Kuraishy, AI Al-Gareeb, A Alexiou… - Current Drug …, 2022 - benthamdirect.com
Covid-19 may be associated with various neurological disorders, including dysautonomia, a
dysfunction of the autonomic nervous system (ANS). In Covid-19, hypoxia …